In the study by Cheng et al., they gave supplements with EPA and DHA or a placebo to 60 patients with lung cancer for 12 weeks and observed that the experimental group had a higher weight and reduction in inflammatory markers such as TNF and CRP compared with the control group [21]. The gene discussed is TNF; the disease is lung carcinoma.